Mercado de medicamentos para la esclerosis múltiple: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00016386
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

INTRODUCCIÓN AL MERCADO La esclerosis múltiple es una enfermedad del cerebro y de la médula espinal. En la esclerosis múltiple, el sistema inmunológico ataca la capa protectora del cerebro, la mielina, que cubre el cerebro y los nervios, provocando problemas de comunicación entre el cerebro y el resto del cuerpo, lo que provoca una función inadecuada del SNC y discapacidad. Se utilizan varios medicamentos para tratar la EM, incluidos agentes inmunomoduladores, interferones y algunos otros. DINÁMICA DEL MERCADO Los impulsores clave del mercado de medicamentos para la esclerosis múltiple incluyen varias iniciativas gubernamentales para el diagnóstico y tratamiento de la esclerosis múltiple, así como un mejor gasto en atención médica en los países desarrollados, que se espera que impulsen el crecimiento del mercado. Además, también se espera que las inversiones en I+D de las empresas farmacéuticas para desarrollar nuevas terapias impulsen el crecimiento del mercado. Sin embargo, se espera que el alto costo de los medicamentos para la esclerosis múltiple junto con los posibles efectos secundarios del tratamiento obstaculicen el crecimiento del mercado durante el pronóstico. ALCANCE DEL MERCADO El “Mercado de Medicamentos para la Esclerosis Múltiple” es un estudio especializado y en profundidad de la industria farmacéutica con un enfoque especial en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una visión general del mercado de medicamentos para la esclerosis múltiple con una segmentación detallada del mercado por clase de medicamento, vía de administración y canal de distribución. Se espera que el mercado de medicamentos para la esclerosis múltiple experimente un alto crecimiento durante el período previsto. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores en el mercado de Medicamentos para la esclerosis múltiple y proporciona tendencias y oportunidades clave en el mercado. SEGMENTACIÓN DEL MERCADO El mercado de medicamentos para la esclerosis múltiple está segmentado según la clase de medicamento, la vía de administración y el canal de distribución. Según la clase de fármaco, el mercado se segmenta en agentes inmunomoduladores, inmunosupresores e interferones. Según la vía de administración, el mercado se segmenta en administración oral y parenteral. Y según el canal de distribución, el mercado se segmenta en farmacias hospitalarias, farmacias minoristas y farmacias online. El informe proporciona una descripción detallada de la industria, incluyendo información cualitativa y cuantitativa. Proporciona una descripción general y un pronóstico del mercado de medicamentos para la esclerosis múltiple en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico para los años 2021 a 2031 con respecto a cinco regiones principales, a saber: América del Norte, Europa, Asia Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur y Central. El mercado de medicamentos para la esclerosis múltiple por región se divide posteriormente en los respectivos países y segmentos. El informe incluye análisis y pronósticos para 18 países de todo el mundo, así como tendencias y oportunidades actuales en la región. El informe analiza los factores que afectan el mercado de Medicamentos para la esclerosis múltiple tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis completo de plagas para las cinco regiones, a saber: América del Norte, Europa, APAC, MEA y América del Sur y Central después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de medicamentos para la esclerosis múltiple en estas regiones. PARTICIPANTES DEL MERCADO El informe cubre desarrollos clave en las estrategias de crecimiento orgánico e inorgánico del mercado de medicamentos para la esclerosis múltiple. Varias empresas se centran en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las estrategias de crecimiento inorgánico observadas en el mercado incluyeron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de la base de negocios y clientes de los participantes del mercado. Debido a la creciente demanda de medicamentos para la esclerosis múltiple en el mercado global, se espera que los actores del mercado de medicamentos para la esclerosis múltiple tengan oportunidades de crecimiento lucrativas en el futuro. A continuación se muestra una lista de algunas de las empresas que operan en el mercado de medicamentos para la esclerosis múltiple. El informe también incluye los perfiles de actores clave en el mercado de medicamentos para la esclerosis múltiple junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos tres años y desarrollos clave en los últimos cinco años. - Biogen - Phizer, Inc - F. Hoffmann La-Roche Ltd - Novartis AG - Merck and Co, Inc - GlaxoSmithKline, Plc - Sanofi - Teva Pharmaceuticals - Bristol Myers Squibb Company - El dedicado equipo de investigación y análisis de Bayer Insight Partner está formado por personal experimentado profesionales con experiencia estadística avanzada y ofrece varias opciones de personalización en el estudio existente.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1.Biogen
2.Pfizer, Inc
3.F. Hoffmann La-Roche Ltd
4.Novartis AG
5.Merck and Co, Inc
6.Sanofi
7.Teva Pharmaceuticals
8.Bristol Myers Squibb Company
9.Bayer
10.GlaxoSmithKline

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.